Modular Medical (MODD) Long-Term Deferred Tax (2022 - 2023)

Modular Medical (MODD) posted Long-Term Deferred Tax of $14.9 million for Q1 2023, up 41.96% on a QoQ basis from $10.5 million in Q1 2022, and up 41.96% year-over-year from $10.5 million in Q1 2022.

Modular Medical (MODD) Long-Term Deferred Tax (2022 - 2023) Analysis & Trends

Modular Medical's Long-Term Deferred Tax history runs 2 years deep, the most recent figure standing at $14.9 million for Q1 2023.

  • Quarterly Long-Term Deferred Tax rose 41.96% year-over-year to $14.9 million in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $14.9 million (up 41.96% YoY) and the FY2023 annual result came in at $14.9 million, up 41.96% from the prior year.
  • Long-Term Deferred Tax was $14.9 million for Q1 2023 at Modular Medical, up from $10.5 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $14.9 million in Q1 2023 and bottomed at $10.5 million in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn
10 Modular Medical 5.28 Mn -1.66 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2023 14.93 Mn
Mar 31, 2022 10.52 Mn